The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience

@article{Cleeland2006TheMO,
  title={The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience},
  author={Charles S. Cleeland},
  journal={Clinical Cancer Research},
  year={2006},
  volume={12},
  pages={6236s - 6242s}
}
  • C. Cleeland
  • Published 15 October 2006
  • Medicine
  • Clinical Cancer Research
Pain is prevalent for large numbers of patients with metastatic cancer, and this pain is often due to bone metastases. Despite the availability of effective pain treatments and various pain management guidelines, multiple studies document the undertreatment of pain in patients with cancer. The most frequently identified barriers to appropriate pain management are physician underestimation of the patient's pain, inadequate pain assessment, and patient reluctance to report pain. A first step… 
View on AACR
clincancerres.aacrjournals.org
102 Citations
Highly Influential Citations
4
Background Citations
26
Methods Citations
19
Results Citations
1

102 Citations

Citation Type

Citation Type

Patterns of pain and interference in patients with painful bone metastases: a brief pain inventory validation study.
Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents
TLDR
Pain outcomes and analgesic use and reported pain data from an integrated analysis of randomized controlled studies of denosumab versus the bisphosphonate zoledronic acid in patients with bone metastases from advanced solid tumors support the use of validated pain assessments to optimize treatment and reduce the burden of pain associated with metastatic bone disease.
Pain in castration-resistant prostate cancer with bone metastases: a qualitative study
TLDR
Qualitative evidence from CRPC patients supports the content validity of the BPI-SF ''Worst Pain' item and promotes use of this item for measuring pain severity in this population, particularly for patients with bone metastases where episodes of BTcP are common.
Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy.
TLDR
Some patients with bone metastases manifest bone pain with distinguishable neuropathic features, and these patients reported greater pain intensity, which is required to explore the unmet pain management needs in this population of patients.
Pain prevalence and treatment in patients with metastatic bone disease
TLDR
The added value of the present study is the suggestion that complete and accurate pain narratives are mandatory and may contribute to the optimization of analgesia, and may help to increase survival rates.
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain.
An investigation into the incidence of pain flare in patients undergoing radiotherapy for symptomatic bone metastases.
Patient-Related Barriers to Effective Cancer Pain Management
TLDR
Patients continue to hold misconceptions about the use and effects of drugs commonly used to manage cancer pain, and interventions designed to raise the awareness of patients seem to help in controlled research studies, but much still needs to be done to address this problem.
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
TLDR
SREs are associated with increased pain and analgesic use in patients with bone metastases and Treatments that prevent SREs may decrease pain and the need for opioid analgesics and reduce the impact of pain on daily functioning.
Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses
TLDR
Higher current pain intensity, sleep disturbances, drowsiness, male gender, and breakthrough pain are factors associated with higher pain intensity in patients with bone metastases at the next follow-up in 1 month, and should be assessed in clinical practice.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Physician Attitudes and Practice in Cancer Pain Management: A Survey From the Eastern Cooperative Oncology Group
TLDR
The knowledge about cancer pain and its treatment among physicians practicing in ECOG-affiliated institutions was determined to determine the methods of pain control being used by these physicians and to compare physician knowledge of and attitudes toward cancerPain with the results of a study of cancer pain.
Undertreatment of cancer pain in elderly patients.
TLDR
The findings of Bernabei 1 et al are consistent with other studies that have reported that cancer pain is poorly man- aged in most settings, and that patient characteristics are predictors of the level of poor pain management.
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group.
TLDR
Although measures of protocol adherence did not suggest the occurrence of major practice change, the proportion of lung or prostate cancer patients with no or mild pain increased significantly from baseline for those treated at AP sites compared with those treating at PD sites.
Pain and its treatment in outpatients with metastatic cancer.
TLDR
The adequacy of prescribed analgesic drugs using guidelines developed by the World Health Organization was assessed, the factors that influenced whether analgesia was adequate were studied, and the effects of inadequate analgesia on the patients' perception of pain relief and functional status were determined.
Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians.
Pain and Treatment of Pain in Minority Patients with Cancer: The Eastern Cooperative Oncology Group Minority Outpatient Pain Study
TLDR
This study compared treatment of pain in patients in this study with that in a subgroup of patients from a previous study who received care in treatment settings in which less than 10% of patients were members of minority ethnic groups, and estimated the adequacy of analgesic prescription by using the Pain Management Index.
Severe undertreatment of cancer pain: a 3-year survey of the German situation.
The analgesic effects that underlie patient satisfaction with treatment
Assessment and treatment of neuropathic cancer pain following WHO guidelines
When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function
...
1
2
3
4
5
...